Thereâs plenty of reason to remain bullish on Novo Nordisk. Even with the challenges it has faced recently, the company ...
The Chosun Ilbo on MSN
Pfizer Sues Novo Nordisk, Metsera in Acquisition Battle
The acquisition battle between global pharmaceutical giants Pfizer and Novo Nordisk over the bio company Metsera is heating ...
Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...
Metsera currently has no products on the market, but is developing oral and injectable treatments for obesity and diabetes.
19hon MSNOpinion
MIKE DAVIS: Foreign weight-loss drugmaker seeks fat profits by gobbling up American upstart
Novo Nordisk attempts to acquire weight-loss drug company Metsera during government shutdown, potentially avoiding FTC ...
Pfizer has filed a lawsuit against Novo Nordisk and Metsera in an attempt to force through its takeover of the weight-loss drug developer and prevent Novo Nordisk from taking its rival bid forward.
The top China executive of US pharmaceutical company Eli Lilly and Co said on Wednesday that the company aims to make its ...
Scripps Research in La Jolla announce a new clinical trial that will assess the effectiveness of using drugs approved for ...
Changes in weight and waist circumference were monitored over 104 weeks, as well as any risk associated with major adverse ...
Novo Nordisk and Pfizer are showing some desperation in their gloves-off tussle for the obesity-drug assets of Metsera.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback